BOARD OF DIRECTORS

Appointed as President Director for the first period based on the Resolution of the Annual General Meeting of Shareholders (AGMS) for the 2023 Financial Year on 25 June 2024 to serve until the GMS for the 2029 Financial Year.

Completed MBA General Management, IPMI International Business School and Bachelor of Laws from University of Indonesia. Previously held the position of President Director at PT Kimia Farma Trading & Distribution (2023), Country Lead at Mundipharma Indonesia (2022-2023), President Director at Viva Health Indonesia (2021-2022)

Appointed as Director of Finance & Risk Management for the first period based on the Resolutions of the Annual General Meeting of Shareholders (GMS) for Fiscal Year 2020 on April 28, 2021 to serve until the GMS for Fiscal Year 2025.

She holds a Masters in Management from the University of Indonesia and a Bachelor in Agriculture from Andalas University. Her previous positions were SEVP Corporate Banking at PT Bank Rakyat Indonesia (Persero) Tbk (2019-2021), Head of Agribusiness Division PT BRI (Persero) Tbk (2018-2019), and Head of Credit Risk Analysis Division at PT BRI (Persero) Tbk ( 2016-2017).

Appointed as Commercial Director for the first period based on the Resolutions of the 2022 Extraordinary General Meeting of Shareholders (EGMS) on 14 October 2022 to serve until the 2027 Fiscal Year General Meeting of Shareholders.

Completed her Bachelor of Economics education at STIE IBB. The positions she has held are President Director of PT Kimia Farma Trading & Distribution (2021-2022), Marketing Director of PT Phapros Tbk (2016-2021), Operations Director of PT Rajawali Nusindo (2012-2016).

Appointed as Director of Human Resources for the first period based on the Resolution of the General Meeting of Shareholders (GMS) for the 2023 Financial Year on 25 June 2024 to serve until the GMS for the 2029 Financial Year.

Completed a Masters in Economic Law at the University of Indonesia and a Bachelor of Laws at the Islamic University of Jakarta. Positions previously held are Legal Specialist at PT Biofarma (Persero) (2023), SEVP HC & Compliance PT Biofarma (Persero) (2019-2023), Director of HR & General Affairs PT Biofarma (Persero) (2017-2019)

Appointed as Director of Production & Supply Chain for the first period based on the Resolutions of the 2023 Extraordinary General Meeting of Shareholders (EGMS) on October 13, 2023 to serve until the AGMS for Fiscal Year 2028.

Completed his Masters in Magister Management at Universitas Negeri Jakarta and completed his professional education in pharmacists at Universitas Gadjah Mada. Several positions that have been held are President Director of PT Phapros Tbk (2020 - 2023), General Manager of TMO PT Kimia Farma Tbk (2019-2020), and General Manager of Manufacture PT Kimia Farma Tbk (2018-2019)

Appointed for the first time as Director of Portfolio and Business Development based on the Resolutions of the 2019 Extraordinary General Meeting of Shareholders (EGMS) on 18 August 2021 to serve until the 2025 Fiscal Year General Meeting of Shareholders

Completed Master of Science in Cellular and Molecular Biology, San Francisco State University and Doctorate in Biochemistry & Molecular Biology, University of California San Francisco. Some of the positions she has held are Director, European Medical & Technical Affairs, The Procter & Gamble Company, Head, Global Medical & Technical Affairs, The Procter & Gamble Company and Head, Asia-Pacific Regulatory Affairs The Procter & Gamble Company